CIK 0001653087
- Accelerated filer
- Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 822933343
- Phone
- +1 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-24 | ORBIMED ADVISORS LLC 10% owner | Sale | −16,409 | $24.45 | $401K | 2,093,927 |
| 2020-03-23 | ORBIMED ADVISORS LLC 10% owner | Sale | −11,057 | $26.05 | $288K | 6,591,410 |
| 2020-03-23 | ORBIMED ADVISORS LLC 10% owner | Sale | −3,541 | $26.05 | $92K | 2,110,336 |
| 2020-03-13 | Paul Robert Chief Medical Officer | Sale | −1,481 | $21.57 | $32K | 262,238 |
| 2020-03-13 | Paul Robert Chief Medical Officer | Sale | −2,884 | $22.47 | $65K | 259,354 |
| 2020-03-13 | Paul Robert Chief Medical Officer | Sale | −5,459 | $23.49 | $128K | 253,895 |
| 2020-03-13 | Paul Robert Chief Medical Officer | Sale | −176 | $24.46 | $4K | 253,719 |
| 2020-03-02 | ORBIMED ADVISORS LLC 10% owner | Sale | −1,390,309 | $26.00 | $36.1M | 6,602,467 |
| 2020-03-02 | ORBIMED ADVISORS LLC 10% owner | Sale | −445,086 | $26.00 | $11.6M | 2,113,877 |
| 2020-03-02 | ORBIMED ADVISORS LLC 10% owner | Sale | −38,808 | $26.00 | $1.0M | 0 |
| 2020-02-14 | King Robert Chief Development Officer | Sale | −4,668 | $29.09 | $136K | 502,649 |
| 2020-02-14 | King Robert Chief Development Officer | Sale | −10,332 | $29.77 | $308K | 492,317 |
| 2020-02-14 | Paul Robert Chief Medical Officer | Sale | −3,000 | $29.07 | $87K | 270,719 |
| 2020-02-14 | Paul Robert Chief Medical Officer | Sale | −7,000 | $29.74 | $208K | 263,719 |
| 2020-02-07 | Oney Sabah Chief Business Officer | Sale | −19,900 | $35.03 | $697K | 573,918 |
| 2020-02-07 | Yu Calvin Vice President, Finance | Sale | −24,033 | $35.02 | $842K | 110,686 |
| 2020-02-06 | Yu Calvin Vice President, Finance | Sale | −2,621 | $35.00 | $92K | 124,494 |
| 2020-02-06 | Oney Sabah Chief Business Officer | Sale | −100 | $35.00 | $4K | 593,818 |
| 2020-02-05 | Paul Robert Chief Medical Officer | Sale | −10,000 | $32.10 | $321K | 273,719 |
| 2020-02-04 | Oney Sabah Chief Business Officer | Sale | −16,667 | $30.00 | $500K | 593,918 |
Page 10 of 13 · 249 trades